Konu "cobimetinib" için PubMed İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 1, listelenen: 1-1
-
A novel side effect of mitogen-activated protein kinase inhibitor cobimetinib: Acute corneal decompensation
(Wolters Kluwer Medknow Publications, 2019)A 38-year-old man with a diagnosis of BRAF-mutated metastatic melanoma was referred to our clinic. He had been under treatment with 60-mg oral cobimetinib daily for 21 days/7 day off in combination with 960 mg vemurafenib ...